Delinia, Inc.

Celgene Corp. has invested billions of dollars in its inflammation and immunology (I&I) franchise through internal development as well as partnered programs and acquisitions, so a few setbacks on the

Celgene Corp. took its traditional place as the opening act for the J.P. Morgan Healthcare Conference in San Francisco last week and despite unveiling a deal to buy Impact Biomedicines , there we

TxCell SA CEO Stéphane Boissel earned his money the day he decided to change the company's strategy, technology focus and in fact the overall organization. When he joined the Sophia Antipolis (Nice,

Johnson & Johnson has made a big push with its JLabs life science incubators, with locations in the US biotechnology hubs of San Diego, San Francisco and Boston as well as in Houston, Texas and Toro